Compare Amphastar Pharmaceuticals Inc (AMPH) vs NetFlix Inc (NFLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs NetFlix Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while NetFlix Inc trades at $74.61 (market cap $317.67B). The key difference: NetFlix Inc is far larger — about 367.7× Amphastar Pharmaceuticals Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, NetFlix Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | NFLX | |
|---|---|---|
Market Cap | $863.95M | $317.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $126.33 |
52-Week Low | $16.87 | $67.60 |
Enterprise Value | $1.26B | $322.85B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
Netflix (NFLX) trades at $74.79, up 0.88% on the day, showing resilience amid recent volatility. The stock exhibits strong fundamentals with robust revenue growth, expanding net income margins, and consistent earnings beats. Technical analysis indicates a bullish trend with key support at $74 and resistance at $77. Recent news highlights focus on the company's advertising business expansion and content performance.
The outlook for NFLX remains positive driven by advertising revenue growth and global subscriber expansion. Key risks include intense streaming competition and market sentiment shifts. Analyst consensus is strongly bullish with a $90.45 price target, suggesting significant upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About NetFlix Inc
Netflix Inc. is an Internet subscription service for watching television shows and movies. Subscribers can instantly watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices and in the United States, subscribers can receive standard definition DVDs and Blu-ray Discs delivered to their homes.
Read more on NFLX →
